FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088978840> ?p ?o ?g. }

• W2088978840 endingPage "146" @default.
• W2088978840 startingPage "139" @default.
• W2088978840 abstract "The four-kallikrein panel and the Prostate Health Index (PHI) have been shown to improve prediction of prostate cancer (PCa) compared with prostate-specific antigen (PSA). No comparison of the four-kallikrein panel and PHI has been presented.To compare the four-kallikrein panel and PHI for predicting PCa in an independent cohort.Participants were from a population-based cohort of PSA-tested men in Stockholm County. We included 531 men with PSA levels between 3 and 15 ng/ml undergoing first-time prostate biopsy during 2010-2012.Models were fitted to case status. We computed calibration curves, the area under the receiver-operating characteristics curve (AUC), decision curves, and percentage of saved biopsies.The four-kallikrein panel showed AUCs of 69.0 when predicting any-grade PCa and 71.8 when predicting high-grade cancer (Gleason score ≥7). Similar values were found for PHI: 70.4 and 71.1, respectively. Both models had higher AUCs than a base model with PSA value and age (p<0.0001 for both); differences between models were not significant. Sensitivity analyses including men with any PSA level or a previous biopsy did not materially affect our findings. Using 10% predicted risk of high-grade PCa by the four-kallikrein panel or PHI of 39 as cut-off for biopsy saved 29% of performed biopsies at a cost of delayed diagnosis for 10% of the men with high-grade cancers. Both models showed limited net benefit in decision analysis. The main study limitation was lack of digital rectal examination data and biopsy decision being based on PSA information.The four-kallikrein panel and PHI similarly improved discrimination when predicting PCa and high-grade PCa. Both are simple blood tests that can reduce the number of unnecessary biopsies compared with screening with total PSA, representing an important new option to reduce harm.Prostate-specific antigen screening is controversial due to limitations of the test. We found that two blood tests, the Prostate Health Index and the four-kallikrein panel, performed similarly and could both aid in decision making among Swedish men undergoing a prostate biopsy." @default.
• W2088978840 created "2016-06-24" @default.
• W2088978840 creator A5021982213 @default.
• W2088978840 creator A5024500466 @default.
• W2088978840 creator A5041375500 @default.
• W2088978840 creator A5052299820 @default.
• W2088978840 creator A5056770711 @default.
• W2088978840 creator A5073429275 @default.
• W2088978840 date "2015-07-01" @default.
• W2088978840 modified "2023-10-12" @default.
• W2088978840 title "Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer" @default.
• W2088978840 cites W1487984827 @default.
• W2088978840 cites W1965638973 @default.
• W2088978840 cites W1990997944 @default.
• W2088978840 cites W2027617068 @default.
• W2088978840 cites W2032359663 @default.
• W2088978840 cites W2045030989 @default.
• W2088978840 cites W2081436827 @default.
• W2088978840 cites W2103764347 @default.
• W2088978840 cites W2111089373 @default.
• W2088978840 cites W2115504452 @default.
• W2088978840 cites W2115948952 @default.
• W2088978840 cites W2125366716 @default.
• W2088978840 cites W2131756199 @default.
• W2088978840 cites W2133219557 @default.
• W2088978840 cites W2142912172 @default.
• W2088978840 cites W2144762283 @default.
• W2088978840 cites W2145062298 @default.
• W2088978840 cites W2148934838 @default.
• W2088978840 cites W2154558741 @default.
• W2088978840 cites W2159085160 @default.
• W2088978840 cites W2328176404 @default.
• W2088978840 cites W4300661369 @default.
• W2088978840 doi "https://doi.org/10.1016/j.eururo.2014.08.010" @default.
• W2088978840 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4503229" @default.
• W2088978840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25151013" @default.
• W2088978840 hasPublicationYear "2015" @default.
• W2088978840 type Work @default.
• W2088978840 sameAs 2088978840 @default.
• W2088978840 citedByCount "154" @default.
• W2088978840 countsByYear W20889788402015 @default.
• W2088978840 countsByYear W20889788402016 @default.
• W2088978840 countsByYear W20889788402017 @default.
• W2088978840 countsByYear W20889788402018 @default.
• W2088978840 countsByYear W20889788402019 @default.
• W2088978840 countsByYear W20889788402020 @default.
• W2088978840 countsByYear W20889788402021 @default.
• W2088978840 countsByYear W20889788402022 @default.
• W2088978840 countsByYear W20889788402023 @default.
• W2088978840 crossrefType "journal-article" @default.
• W2088978840 hasAuthorship W2088978840A5021982213 @default.
• W2088978840 hasAuthorship W2088978840A5024500466 @default.
• W2088978840 hasAuthorship W2088978840A5041375500 @default.
• W2088978840 hasAuthorship W2088978840A5052299820 @default.
• W2088978840 hasAuthorship W2088978840A5056770711 @default.
• W2088978840 hasAuthorship W2088978840A5073429275 @default.
• W2088978840 hasBestOaLocation W20889788402 @default.
• W2088978840 hasConcept C121608353 @default.
• W2088978840 hasConcept C126322002 @default.
• W2088978840 hasConcept C126894567 @default.
• W2088978840 hasConcept C143998085 @default.
• W2088978840 hasConcept C181199279 @default.
• W2088978840 hasConcept C185592680 @default.
• W2088978840 hasConcept C2775934546 @default.
• W2088978840 hasConcept C2776235491 @default.
• W2088978840 hasConcept C2780101318 @default.
• W2088978840 hasConcept C2780192828 @default.
• W2088978840 hasConcept C2781217009 @default.
• W2088978840 hasConcept C2781406297 @default.
• W2088978840 hasConcept C29456083 @default.
• W2088978840 hasConcept C52853521 @default.
• W2088978840 hasConcept C55493867 @default.
• W2088978840 hasConcept C58471807 @default.
• W2088978840 hasConcept C71924100 @default.
• W2088978840 hasConcept C72563966 @default.
• W2088978840 hasConcept C76318530 @default.
• W2088978840 hasConceptScore W2088978840C121608353 @default.
• W2088978840 hasConceptScore W2088978840C126322002 @default.
• W2088978840 hasConceptScore W2088978840C126894567 @default.
• W2088978840 hasConceptScore W2088978840C143998085 @default.
• W2088978840 hasConceptScore W2088978840C181199279 @default.
• W2088978840 hasConceptScore W2088978840C185592680 @default.
• W2088978840 hasConceptScore W2088978840C2775934546 @default.
• W2088978840 hasConceptScore W2088978840C2776235491 @default.
• W2088978840 hasConceptScore W2088978840C2780101318 @default.
• W2088978840 hasConceptScore W2088978840C2780192828 @default.
• W2088978840 hasConceptScore W2088978840C2781217009 @default.
• W2088978840 hasConceptScore W2088978840C2781406297 @default.
• W2088978840 hasConceptScore W2088978840C29456083 @default.
• W2088978840 hasConceptScore W2088978840C52853521 @default.
• W2088978840 hasConceptScore W2088978840C55493867 @default.
• W2088978840 hasConceptScore W2088978840C58471807 @default.
• W2088978840 hasConceptScore W2088978840C71924100 @default.
• W2088978840 hasConceptScore W2088978840C72563966 @default.
• W2088978840 hasConceptScore W2088978840C76318530 @default.
• W2088978840 hasIssue "1" @default.
• W2088978840 hasLocation W20889788401 @default.
• W2088978840 hasLocation W20889788402 @default.

• next